An early option for women. Danco Laboratories, a women's health pharmaceutical company, is pleased to present Mifeprex, the first Food and Drug Administration approved pill for ending early pregnancy. Mifeprex is safe and effective. Taken orally, it is non-invasive, avoiding surgery or anesthesia in most cases.
Some women feel it is a more private option.
When women choose the early option pill, they will receive counseling and support throughout the process. Available directly from a doctor's office or clinic, Mifeprex can be taken from the time a woman knows she is pregnant up to seven weeks after the beginning of her last menstrual period. Mifeprex works by blocking a hormone necessary to sustain a pregnancy. Mifeprex is followed by misoprostol, a drug that helps end pregnancy. Bleeding and cramping are a normal part of the process.